|
1. After patient deaths, FDA to trim gene therapy's approval Full story
2. Pfizer to sell $508M stake in BioNTech Full story
3. Prevention > treatment: See how UW Health and others are making precision medicine pay off here.

4. FDA approves 1st biosimilar to breast cancer drug Perjeta Full story
5. FDA opens new approval route for personalized treatments Full story

6. 2026 will test every clinical leader — how UPMC, Kaiser + others are preparing here.
7. Ozempic, Wegovy to be sold at $199 a month for new patients Full story
8. FDA approves 1-minute HIV self-test Full story
Becker's Learning Opportunities
9. CoxHealth turned virtual care into a 'collaborative engine' across 6 hospitals. See the model here.
10. Clinicians want clear IUD pain protocols. Evidence-based strategies you can use today here.
11. How Providence, WVU Medicine + others are tackling capital pressure and capacity strain: here.
12. Becker’s resources don’t stop here — explore more
webinars and
whitepapers.
Apply to attend complimentary as a guest reviewer here! Opportunity exclusive to those directly employed by a provider organization.
|